Nationwide Children's Hospital, Columbus, OH, USA.
The Ohio State University, Columbus, USA.
J Atten Disord. 2021 Dec;25(14):2028-2036. doi: 10.1177/1087054720956727. Epub 2020 Sep 18.
The aim of this paper is to understand associations between age and health care provider type in medication continuation among transition-aged youth with ADHD.
Using an employer-sponsored insurance claims database, we identified patients with likely ADHD and receipt of ADHD medications. Among patients who had an outpatient physician visit at baseline and maintained enrollment at follow-up 3 years later, we evaluated which ones continued to fill prescriptions for ADHD medications.
Patients who were younger at follow-up more frequently continued medication (77% of 11-12 year-olds vs. 52% of 19-20 year-olds). Those who saw a pediatric provider at baseline and follow-up more frequently continued to fill ADHD medication prescriptions than those who saw a pediatric provider at baseline and non-pediatric providers at follow-up (71% vs. 53% among those ages 15-16 years at follow-up).
Adolescents and young adults with ADHD who changed from pediatric to exclusively non-pediatric providers less frequently continued to receive ADHD medications.
本文旨在了解 ADHD 青少年过渡时期，年龄与医疗服务提供者类型与药物持续使用之间的关联。
本研究使用雇主赞助的保险索赔数据库，确定可能患有 ADHD 并接受 ADHD 药物治疗的患者。在基线时有门诊医生就诊且在 3 年后的随访中仍保持入组的患者中，我们评估了哪些患者继续开 ADHD 药物处方。
随访时年龄较小的患者更频繁地继续服药（11-12 岁的患者中有 77%，而 19-20 岁的患者中有 52%）。与基线和随访时均看儿科医生的患者相比，那些基线时看儿科医生、随访时看非儿科医生的患者更频繁地继续开 ADHD 药物处方（随访时年龄在 15-16 岁的患者中，前者为 71%，后者为 53%）。
从儿科医生转为仅接受非儿科医生治疗的 ADHD 青少年和年轻成年人，继续接受 ADHD 药物治疗的可能性较小。
